Biopeople is acknowledged as a European Cluster Organisation with excellent management and performance. Come and Join Us.
Established in 2008, employing 12 people and with no immediate need for capital, "CytoVac is confident and looking forward to see the first data of their large phase 2 trial in patients with Glioblastoma brain cancer," says Martin Roland, CEO of CytoVac.
Information lies at the very core of most modern life sciences R&D. To keep track of the thousands of thousands of interacting molecules (including super complex DNA molecules) and cell components that together comprise life as we know it, is a daunting task indeed.
3 entries found